logo

For the Inventor, By the Inventor

Laval, Canada

Jacques Jolivet

This inventor holds 2 USPTO granted patents. Top assignee: Shire Biochem, Inc.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Jolivet. Retrieved from https://idiyas.com/inventor/jacques-jolivet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:

goldMedal2 out of 16 
 
Shire Biochem, Inc.
 patents

Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6800639 - Pharmaceutical combination for the treatment of cancer (2004-10-05),
2. 6645972 - Methods of treating leukemia (2003-11-11),

Title: Jacques Jolivet and His Pharmaceutical Patents.

Introduction

Jacques Jolivet is an inventor associated with Laval, Canada, whose patent work concerns pharmaceutical treatments, including approaches to cancer and leukemia.

Latest Patents

The listed patents associated with Jolivet are “Pharmaceutical Combination for the Treatment of Cancer” and “Methods of Treating Leukemia.” He is credited with 2 patents.

Career Highlights

Jolivet is associated with Shire Biochem, Inc. His listed patent work reflects a focus on pharmaceutical inventions and cancer treatment.

Collaborations

His listed coworkers include Francis J. Giles and Hagop Kantarjian.

Conclusion

Jacques Jolivet’s recorded inventions center on pharmaceutical approaches to cancer and leukemia, developed in connection with his work at Shire Biochem, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…